Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Neuropharmacology. 2022 Jan 7;207:108943. doi: 10.1016/j.neuropharm.2022.108943

Figure 4. mGlu3-NAM produces lasting anxiolytic-like behavioral effects.

Figure 4.

mGlu3-NAM treatment 2 weeks before testing resulted in increased time spent in the open arms of the zero-maze test (A) and increased habituation of acoustic startle responses (B). TMT exposure did not affect zero maze or ASR measures. * p≤0.05 significantly different from Control.